Letrozole is prescribed for adult females who’ve gone through menopause to treat certain forms of early breast cancer, locally advanced breast cancer, and metastatic breast cancer. The recommended ...

Novartis Oncology announces that the U.S. Food and Drug Administration has approved Femara(R) (letrozole tablets) for the first-line treatment of postmenopausal women with hormone receptor positive or ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S.

Co announces it has received tentative approval from the FDA for its Abbreviated New Drug Application for Letrozole Tablets U.S.P, 2.5 mg.